Personalized Biomolecular Therapy - A New Frontier on Telomere Rescue Therapy
MIAMI (PRWEB) August 20, 2018 -- Dr. Ivel De Freitas, MD, ABIM, ABAARB, a leader in the field of regenerative and biomolecular medicine, in partnership with SpectraCell Laboratories, will be hosting SpectraCell’s monthly webinar on August 23rd at 8:00pm EST (5:00pm PT, 6:00pm MT, 7:00pm CT): “Personalized Biomolecular Therapy - A New Frontier on Telomere Rescue Therapy.”
SpectraCell Laboratories is a leading clinical laboratory specializing in personalized disease prevention and management solutions.The webinar will explore the most recent medical research in the field of telomere and micronutrient profiling, the relationship between telomeres, quality of life and performance, and the efficacy of micronutrient and biomolecular therapies.
Dr. De Freitas is a pioneer in the development of innovative and unique preventive and regenerative medical protocols. She is the founder and CEO of Onogen, a medical institute that provides specifically formulated intravenous regenerative therapies formulated based on each patient’s unique biomolecular and genetic needs.
“There is an awakening in medicine and especially in the field of regenerative and anti-aging medicine. Today, more than ever, medicine is poised to unleash the potential of informatics and genomics to improve our patients’ lives.” explains Dr. De Freitas. “We have realized that standard of care, “one size fits all”and diagnosis-centered approach are no longer the best strategy to determine individual’s therapies. Applying a biomolecular, genomic and epigenetic patient-centered approach using the latest science to determine individual’s genetic, biomolecular and telomere profiling can not only help us to extend patient’s life span but also deliver a healthier and higher quality of life, known as health-span. The earlier you start the better you can stave off the effects of aging and its related degenerative diseases.”
The significance of telomeres in health and aging came to public attention when Elizabeth H. Blackburn, Carol W. Greider and Jack W. Szostak won the Nobel prize in physiology and medicine in 2009 for their discovery of "how chromosomes are protected by telomeres and the enzyme telomerase." Since then, significant research has shown that keeping our telomeres - the DNA protein caps at the end of chromosomes that protect our genetic data - in optimal condition can protect us from diseases and physiological deterioration associated with ageing.
Taking care of or even reversing the damage on our telomeres is at the heart of the research and the development of the therapies Dr. De Freitas has dedicated her life to.
“Every patient knows that he or she must follow healthy habits as they age - exercise, sleep well, eat healthy, don’t smoke, etc…” says Dr. De Freitas. “But we now know that there is more to that. There are cutting edge medical diagnostics such as SpectraCell’s micronutrient profiling in combination with genetic and telomere length analysis that can provide us with insights to create unique and custom therapies that target an individual's cellular functions at a molecular level, improving individual energy, physical performance, brain clarity, mood and sex drive, impacting every area of individuals’ lifestyle and improving the chance of individuals achieving their maximum potential."
Frequent monitoring and therapy adjustment are also a essential and unique piece of Dr. De Freitas’ method. “Frequent monitoring and adjustment allow us to maintain individual biomolecular balance optimal, boosting individual’s capacity to cope with stress, enhancing his or her physical and mental capacity while promoting well-being, resiliency and healthy longevity. This is revolutionary in the field of medicine.”
To register for the SpectraCell monthly webinar hosted by Dr. Ivel De Freitas, please visit: https://www.spectracell.com/webinars/. Registration is free but space is limited.
To learn more about Onogen therapies and about Dr. Ivel De Freitas, please visit, Onogen.com.
Susy Ferrer, ROCK Group LLC, +1 305-751-5085, [email protected]
Share this article